A prospective, randomized, double-blind, placebo-controlled study on the influence of a hormone replacement therapy on skin aging in postmenopausal women

By Sator P.-G.   Sator M. O.   Schmidt J. B.   Nahavandi H.   Radakovic S.   Huber J. C.   Honigsmann H.  

Climacteric, Vol. 10, Iss. 4, 2007-08 ,pp. : 320-334

Informa Healthcare

Access to resources Recommend Favorite

Gonadotropin-releasing hormone agonist plus ''add-back'' hormone replacement therapy for treatment of endometriosis: a prospective, randomized, placebo-controlled, double-blind trial

By Franke H.R.   van de Weijer P.H.M.   Pennings T.M.M.   van der Mooren M.J.  

Fertility and Sterility, Vol. 74, Iss. 3, 2000-09 ,pp. : 534-539

Elsevier

Access to resources Recommend Favorite

Symptomatic treatment of premenstrual mastalgia in premenopausal women with lisuride maleate: a double-blind placebo-controlled randomized study

By Kaleli S.   Aydin Y.   Erel C.T.   Colgar U.  

Fertility and Sterility, Vol. 75, Iss. 4, 2001-04 ,pp. : 718-723

Elsevier

Access to resources Recommend Favorite

Effect of gonadotropin-releasing hormone agonist and medroxyprogesterone acetate on calcium metabolism: a prospective, randomized, double-blind, placebo-controlled, crossover trial

By Carr B.R.   Breslau N.A.   Peng N.   Adams-Huet B.   Bradshaw K.D.   Steinkampf M.P.  

Fertility and Sterility, Vol. 80, Iss. 5, 2003-11 ,pp. : 1216-1223

Elsevier

Access to resources Recommend Favorite

Estradiol and drospirenone for climacteric symptoms in postmenopausal women: a double-blind, randomized, placebo-controlled study of the safety and efficacy of three dose regimens

By Schurmann R.   Holler T.   Benda N.  

Climacteric, Vol. 7, Iss. 2, 2004-06 ,pp. : 189-196

Informa Healthcare

Access to resources Recommend Favorite